Journal article
Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity
AL Carey, R Pajtak, MF Formosa, B Van Every, DA Bertovic, MJ Anderson, N Eikelis, GW Lambert, V Kalff, SJ Duffy, MH Cherk, BA Kingwell
Diabetologia | SPRINGER | Published : 2015
Abstract
Aims/hypothesis: Brown adipose tissue (BAT) activation increases energy expenditure and may have therapeutic potential to combat obesity. The primary activating and adaptive signal for BAT is via β-adrenergic signalling. We previously demonstrated that human BAT is acutely responsive to oral administration of the sympathomimetic, ephedrine. Here we aimed to determine whether adaptive thermogenesis can be induced via chronic treatment with ephedrine. Methods: Twenty-three healthy young men, recruited from the general public in Melbourne, Australia, who were non-smokers, physically inactive and non-medicated with no prior history of cardiovascular disease or diabetes were recruited for this st..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This study was supported by a National Health and Medical Research Council of Australia Program Grant (1036352) and the OIS scheme from the Victorian State Government. BAK holds a National Health and Medical Research Council Senior Principal Research Fellowship (1059454). GWL holds a National Health and Medical Research Council Senior Principal Research Fellowship (1042492).